To DPP or not to DPP: who trains the trainers? The Pharmaceutical Journal’s health policy columnist considers the value of incentivising designated prescribing practitioners to supervise trainee pharmacists from 2025.…
‘Managing your service’ when the IT does not work This month, our health policy columnist reflects on the IT issues surrounding the roll out of the Pharmacy First service in England.…
Early days of Pharmacy First highlight three things we should study This month, our health policy columnist examines the teething problems thrown up in the first few weeks of the Pharmacy First service.…
Demand, meet supply? This month, our health policy columnist responds to national headlines highlighting the persistent issue with medicine shortages.…
The vision for supervision As 2023 draws to a close, our health policy columnist says pharmacy could be the solution to alleviating workforce issues that continue to plague the NHS.…
Putting Pharmacy First: a welcome change of policy Pharmacy First requires careful implementation but provides an opportunity, says The Pharmaceutical Journal’s health policy columnist.…
The phantom pharmacy sector This month, The Pharmaceutical Journal’s health policy columnist considers the impact of recent changes to the pharmacy market.…
The contrast in reactions to growing roles for pharmacy technicians and physician associates The Pharmaceutical Journal’s health policy columnist considers why pharmacists and doctors have reacted differently to the expanding roles of their colleagues.…
For want of a jab… are vaccines out of fashion for NHS England? This month, The Pharmaceutical Journal’s health policy columnist questions the government’s decisions to reduce the COVID-19 vaccination fee and delay the flu vaccination programme.…
Why are we ‘Booting’ out community pharmacy capacity? This month, The Pharmaceutical Journal’s health policy columnist analyses the practical and financial implications of widespread community pharmacy closures.…
